NCT06989463

Brief Summary

Childhood cancer survivors are at risk for accelerated aging due to the specific treatments they have received to cure their cancer. Several interventions, including exercise, cognitive training, and mindfulness practice, have been developed and studied for effectiveness among participants in the St. Jude Lifetime Cohort (SJLIFE) to mitigate these effects. The interventions offered thus far have not included two components at the same time. The purpose of this study is to determine whether or not adult cancer survivors enrolled in SJLIFE will participate in two interventions at the same time. The combined interventions will include exercise plus cognitive training or exercise plus mindfulness practice. Each intervention will be conducted over a 12-week period. Participants will also be asked to complete follow-up testing after the 12-week intervention period is completed. Primary Objectives

  • To determine the acceptability of a two-component intervention (exercise (EX) plus cognitive training (CT) or exercise (EX) plus mindfulness practice (MP)) among survivors of childhood cancer with either cognitive impairment or emotional distress. Hypotheses:
  • 45% of those approached for participation in each arm of this study will enroll on the study.
  • Among those who enroll, 70% will complete the follow-up testing at 12 weeks.
  • Among those who completed the follow-up testing, the mean attendance to the intervention sessions will be 70% on each of their two interventions. That is, they will complete 70% of exercise sessions and 70% of either cognitive training or mindfulness practice.
  • To identify barriers and facilitators to intervention adherence. Hypotheses:
  • Participants will identify features of the study processes that either facilitate or discourage adherence.
  • Participants will identify features of the intervention technology and intervention components that either facilitate or discourage adherence.
  • Participants will identify personal factors that facilitate or discourage adherence.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
6mo left

Started Jul 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress61%
Jul 2025Nov 2026

First Submitted

Initial submission to the registry

May 8, 2025

Completed
17 days until next milestone

First Posted

Study publicly available on registry

May 25, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

July 29, 2025

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2026

Expected
Last Updated

April 24, 2026

Status Verified

April 1, 2026

Enrollment Period

9 months

First QC Date

May 8, 2025

Last Update Submit

April 23, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Enrollment rate (%)

    The percentage of the number of participants approached for participation compared to those who enroll on study

    Through study completion or an average of 24 months

  • Follow up completion rate (%)

    The percentage of the number of participants who complete the 12-week testing compared to who enroll on study

    Through study completion or an average of 24 months

  • Intervention adherence rate for those participants who complete the final follow up visit (%)

    The percentage of the intervention sessions attended v offered (n=24)

    Through study completion or an average of 24 months

Study Arms (2)

Exercise (EX) plus Cognitive Training (CT)

ACTIVE COMPARATOR

Adult survivor of childhood cancer enrolled in St. Jude Life Cohort (SJLIFE) at least five years from diagnosis. Participants pre-identified as cognitively impaired will be assigned to the EX+CT arm

Other: 12 Week Exercise InterventionOther: Cognitive Training Intervention

Exercise (EX) plus Mindfulness Practice (MP)

ACTIVE COMPARATOR

Adult survivor of childhood cancer enrolled in St. Jude Life Cohort (SJLIFE) at least five years from diagnosis. Participants pre-identified as emotionally impaired will be assigned to the EX+MP arm.

Other: 12 Week Exercise InterventionOther: Mindfulness practice intervention

Interventions

Participants will complete cognitive training with Lumosity (Lumos Labs, Inc.; San Francisco, California; cognitive training program). This computer-based training consists of games focused on specific executive function skills (shifting attention, working memory, verbal fluency, problem solving). Each 20-minute session includes five games focused specifically on these executive functioning skills. Participants will be prescribed three 20-minute sessions each week for 12-weeks.

Exercise (EX) plus Cognitive Training (CT)

The mindfulness practice intervention is a modified version of the University of California at Los Angeles Mindfulness Awareness Research Center's Mindful Awareness Practices designated to be remotely delivered. during odd weeks, participants will watch the educational lecture video once and practice meditation daily. During even weeks, they will review the educational video as needed and continue daily meditation practice.

Exercise (EX) plus Mindfulness Practice (MP)

Participants will be provided with the results of their physical functioning and fitness assessments and will receive an individually tailored exercise prescription, written by an exercise specialist and approved by the study physician. The prescription will include aerobic and strengthening components designed to progress persons gradually to 150-300 minutes of the equivalent of moderate aerobic activity and twice weekly strengthening106 over 12 weeks.

Exercise (EX) plus Cognitive Training (CT)Exercise (EX) plus Mindfulness Practice (MP)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants enrolled in St. Jude Lifetime Cohort (SJLIFE) \>18 years of age.
  • Participant has been pre-identified as both physically impaired (T score ≤45 on the physical function and/or role physical subscales of the Medical Outcomes Survey Short Form 36 (SF-36)), and either cognitively (standard score \>84th percentile on the Childhood Cancer Survivor Study Neurocognitive Questionnaire) or emotionally impaired (T scored score ≥ 63 on the Brief Symptom Inventory) from the most recently completed SJLIFE survey questionnaires.
  • Participant self-reports participating in \<150 minutes of moderate to vigorous physical activity per week (Centers for Disease Control Physical Activity Guidelines for Americans).
  • Participant has been medically cleared to participate in physical activity.
  • Participant verbalizing understanding of the directions to use the digital platform on provided laptop/tablet.

You may not qualify if:

  • Participant cannot speak, read, and/or understand English.
  • Participant is a woman and currently pregnant.
  • Participant reports engaging in mindfulness-based training or continuously practiced mindfulness techniques over the past 6 weeks.
  • Participant has an estimated intelligence score (FSIQ) \<80.
  • Participant has a diagnosis of post-traumatic stress disorder, major psychiatric condition, and/or history of suicidal ideation or self-harm.
  • Participant reports alcohol or drug abuse in the past year (Alcohol Use Disorders Identification Test (AUDIT) \>=13/women and \>=15/men or Drug Abuse Screen Test (DAST) -10\>3).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Jude Children's Research Hospital

Memphis, Tennessee, 38105, United States

Location

Related Links

Study Officials

  • Kirsten K Ness, PhD

    St. Jude Children's Research Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 8, 2025

First Posted

May 25, 2025

Study Start

July 29, 2025

Primary Completion

May 1, 2026

Study Completion (Estimated)

November 1, 2026

Last Updated

April 24, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

Individual participant de-identified datasets containing the variables analyzed in the published article will be made available (related to the study primary or secondary objectives contained in the publication). Supporting documents such as the protocol, statistical analyses plan, and informed consent are available through the ClinicalTrials.gov (CTG) website for the specific study. Data used to generate the published article will be made available at the time of article publication. Investigators who seek access to individual level de-identified data will contact the computing team in the Department of Biostatistics (ClinTrialDataRequest@stjude.org) who will respond to the data request.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Data will be made available at the time of article publication.
Access Criteria
Data will be provided to researchers following a formal request with the following information: full name of requestor, affiliation, data set requested, and timing of when data is needed. As an informational point, the lead statistician and study principal investigator will be informed that primary results datasets have been requested.

Locations